Stockguru.com: Stocks to Watch for November 18, 2008 - ICPR, GMPM, NMXC, PCYG, GTXO, and NPHC

Nov 18, 2008 (M2 PRESSWIRE via COMTEX) -- PCYG | Quote | Chart | News | PowerRating -- Our Stocks to Watch today include : ICP Solar Technologies Inc. (OTCBB: ICPR), Gamma Pharmaceuticals Inc. (OTCBB: GMPM), New Mexico Software, Inc. (OTCBB: NMXC), Park City Group, Inc. (OTCBB: PCYG), GTX Corp (OTCBB: GTXO), and Nutra Pharma Corp. (OTCBB: NPHC)

Visit: http://www.stockguru.com to register for our daily Stocks to Watch and Trade Alerts.

ICP Solar Technologies Inc. (OTCBB: ICPR | Quote | Chart | News | PowerRating) Shares traded down 22.94% at $0.262

ICP Solar is a developer, manufacturer and marketer of solar panels, solar cell based products, solar monitoring software and solar power management solutions. Through the application of its own intellectual property and next-generation technologies, the Company aims to be the solar industry's innovation leader. For the past 20 years, ICP Solar has been a lead innovator in the consumer solar market and has now begun to apply that same innovation philosophy to the OEM, rooftop and power generation segment of the solar industry. ICP Solar's management has over 50 years of experience in the renewable energy sector. ICP Solar markets its products under its Sunsei brand of solar products and is the North American licensee of the Coleman brand in the solar charger category. ICP Solar is also helping the environment by offering these solar technologies and green solutions to the renewable energy sector. The company's headquarters are located in Montreal, Canada, with an R&D center in St. John's Canada and additional locations in the USA, Ireland, France and the UK.

ICPR News Yesterday, ICP Solar Technologies announced that The Company will begin shipping its new, patented, Sunsei GreenMeter this month. The initial customer, an education products company, will be installing the GreenMeter in 30 high schools across North America providing scientific training stations for labs within a curriculum that focuses on renewable energy. The Sunsei GreenMeter hybrid energy monitor will be the centerpiece of these stations, and it will interface with solar panels, wind turbines, and a battery system that monitors energy output. Students can measure electrical power production from both solar and wind sources, analyzing the resulting energy vis-A-vis existing weather conditions.

Gamma Pharmaceuticals Inc. (OTCBB: GMPM | Quote | Chart | News | PowerRating) Shares traded down 1.79% at $0.55

Gamma Pharmaceuticals, Inc. operates as a marketing, brand management, and product formulation company. The company focuses on the formulation, marketing and sale of vitamins and nutriceuticals, over the counter pharmaceutical products, and personal care products in the Peoples Republic of China, Hong Kong, Taiwan, and the United States. Its product formulations are based on its proprietary ?Gel Delivery Technology? and are marketed and sold as wellness products. The company offers a suite of gel product forms, including gummy gels, liquid gels, crystal gels, and gel strips. Its products include hand sanitizer lotion, supplement multivitamins, supplement calcium, supplement vitamin C, and adjunctive supplement immune boosters and energy boosters, as well as for improved cognition, reducing the side effects of chemotherapy, symptoms of type II diabetes and pre-diabetes, symptoms of menopause, and stress reduction. The company offers products under the BrilliantChoice, Savvy, Jugular Energy Products, and IceDrops. It also manufactures house brands for retail accounts. The company, formerly known as Sunburst Pharmaceuticals, Inc., was founded in 1993 and is headquartered in Las Vegas, Nevada.

GMPM News Yesterday,Gamma Pharmaceuticals announces the launch of its annual private label program for 2008-2009. Gamma's 2008-2009 program is a continuation and expansion of our highly successful 2007 rollout of a gum drop based immune booster with a national retail pharmacy chain. Gamma's immune booster reached the rank of top new product in the cough and cold category at this at this retailer. Gamma has agreed to selectively manufacture certain house brands or private label programs for retailers. The Company expects that each individual product (SKU) will achieve $250,000-$350,000 per SKU for house brands.

New Mexico Software, Inc. (OTCBB: NMXC | Quote | Chart | News | PowerRating) Shares traded down 23.33% at $0.023

New Mexico Software, Inc. provides software-as-a-service solutions. The company develops and markets Internet technology-based software for the management of digital high-resolution graphic images, documents, video clips, and audio recordings. Its products include XR-Express system, a secure HIPAA-compliant system that enables medical providers to examine medical images, such as x-rays, EKG?s, and ultrasounds through the Internet; and Business Express, a hosted online that enables customers to automate common paper tasks with PDF files and Javascript using any Web 2.0 compliant device. The company?s product also include DDS-Express, an online dental solution, including practice management software, clinical charting, online insurance claim filing, digital image storage, referrals and consultations, and secure off-site data backup. In addition, its products include MedConEXpress, a secure HIPAA-compliant system, which enables a referring hospital to transmit digital diagnostic images and reports to a consulting physician related to the quality of neurosurgery, trauma, cardiology, and pediatric care referrals and consultations. The company offers its services through its Web-based technology that allows customers in medical, dental, entertainment, and commercial businesses, as well as not for profit organizations to optimize their operations without spending significant time and money on upfront costs for hardware, software, tech support, and training. New Mexico Software, Inc. was founded in 1980 and is based in Albuquerque, New Mexico.

NMXC News Yesterday,New Mexico Software announced that revenue for the third quarter of 2008 increased 123% to $520,000 from $233,000 in the third quarter of 2007. Net loss for the third quarter was reduced by 74%, to $46,000 from $177,000 in the third quarter of 2007. For the first nine months of 2008, revenue was $957,000, an increase of 29% over $740,000 for the comparable period last year. The net loss for the nine months ended September 30, 2008 was $291,000, compared with a net loss of $422,000 for the nine-month period ended September 30, 2007. New Mexico Software CEO Dick Govatski said, "It's been a fast moving period at the company as characterized by the 123% growth in revenue during the quarter. In May, we set up a special 17-person division to promote and manage our teleradiology services. Since then we have contracted with 25 radiologists nationwide to read images for clients. Our teleradiology services began generating revenue in June and our XR-EXpress obtained the important FDA clearance in October. Our case load has been doubling every month, going from hundreds of cases in June to multiple thousands of cases per month now. More than 107 medical divisions at about 6,900 facilities nationwide are currently using our teleradiology services -- more than double the number from last year."

Park City Group, Inc. (OTCBB: PCYG | Quote | Chart | News | PowerRating) Shares stayed even at $1.40

Park City Group, Inc., together with its subsidiaries, engages in the design, development, and marketing of application software products to supermarkets, convenience stores, and other retailers. It offers Fresh Market Manager, a suite of software product applications designed to help manage perishable food departments, including bakery, deli, seafood, produce, meat, home meal replacement, dairy, frozen food, and floral. This product provides profitability data on a corporate, regional, store-by-store, and item-by-item basis. The company also provides ActionManager, a suite of solutions that forecast labor demand, schedules staff resources, and provides store managers with the necessary tools to keep labor costs under control. It offers an automated method for managers to plan, schedule, and administer the tasks, including new hire paperwork, and time and attendance, as well as dashboard view of the business to the local managers. In addition, Park City Group provides Supply Chain Profit Link that offers daily or weekly store-by-store item level information to suppliers to facilitate decision support. Further, the company provides business consulting services to suppliers and retailers in the grocery, convenience store, and specialty retail industries. It serves retail companies, financial services, branded food manufacturers, and display manufacturing companies primarily in North America, as well as in Europe and Asia. The company was founded in 1990 and is based in Park City, Utah.

PCYG News Yesterday, Park City Group announced financial results for the first quarter ended September 30, 2008. For the first quarter of fiscal 2009 the company reported that revenues decreased 38 percent to $530,278 as compared with $854,264 for the same period last year. Lower revenue results were due in part to a $320,000 reduction in license and maintenance revenues when comparing the quarter ended 2008 with the same period in 2007. As previously announced, in 2007 the Company modified its business strategy to focus on increasing sales of its suite of software products on a subscription basis. The Company will continue to generate licensing revenues, which by their nature are less predictable, and are best evaluated on an annual, rather than quarterly, basis. Total operating expenses for the first quarter of fiscal 2009 were down 17 percent, or $300,843, when compared with the same period in 2008. This is the result of a combination of efficiencies recognized in the pending merger with Prescient which included a reduction in total headcount, a reduction in consultant costs and recruitment fees, and in one-time expenses comprised of patent defense costs and stock compensation expense. This resulted in a net loss applicable to common shareholders of ($1,209,884), or ($0.13) loss per share, as compared with ($737,216), or ($0.08) loss per share, in the same period last year. When excluding one-time items, including income associated with patent activities of $200,000 in first quarter of fiscal 2008 which did not occur in the same period in fiscal 2009, and ($197,205) operating loss associated with the Company's 8 percent investment in Prescient, the adjusted net loss applicable to common shareholders for the period ended September 30, 2008 and 2007 was, ($924,283) and ($854,724), respectively.

GTX Corp (OTCBB: GTXO | Quote | Chart | News | PowerRating) Shares traded up 6.06% at $0.35

GTX Corp. engages in the development and commercialization of miniaturized global positioning system (GPS) tracking technology that uses cellular transmission. It develops patented wireless location products and services for family safety and communications, and law enforcement and security technology solutions. The company offers end-to-end personal location system, which includes an embedded module and a proprietary Location Data Center that delivers remote, continuous real-time oversight of loved ones and high-value assets. Its Locator embedded module combines the assisted GPS and digital personal communications service technologies to provide location and tracking information in real-time for routine and emergency situations through its location data center and Internet infrastructures. The company intends to market its products to prospective licensees who are selling related products or technology services into markets, such as home security and child safety, medical and elder care providers, campers, hikers, backpackers, adventure seekers, extreme sports enthusiasts, freight and cargo carriers, delivery services, pet owners, vehicle finance companies, auto dealerships, law enforcement agencies, military organizations, and individuals wishing to track valuable personal items. GTX Corp. was founded in 2002 and is headquartered in Los Angeles, California.

GTXO News Yesterday, GTX continues to develop and integrate their miniaturized cellular tracking technology, and in their commitment to keep their shareholders informed has provided the following corporate update. As disclosed in the quarterly report for the period ending September 30, 2008, issued November 5, the Company delivered additional shipments of GTX gpVector to its licensee, My Athlete, pushing revenue growth up almost 400% as compared to the previous quarter. GTX had shipped the gpVector module units into their first vertical market in Q2 2008 realizing revenue and sales from its out licensing business model. The My Athlete license agreement is valued at $25 million over five years. This follow-up order is significant because it validates the product's effectiveness, shows that the technology is in demand and exhibits the Company's ability to execute its business model. The repeat orders, the PLS market trending upward, most recently estimated at $13 billion by 2013 (as mentioned in the recent Vista Report) combined with GTX's execution and delivery of products may be an indicator that GTX will increase its delivery of 2-Way GPS technology in 2009.

Nutra Pharma Corp. (OTCBB: NPHC | Quote | Chart | News | PowerRating) Shares traded up 16.67% at $0.035

Nutra Pharma Corp., a biopharmaceutical company, engages in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases. The company, through its subsidiary, ReceptoPharm, Inc., develops RPI-78M for the treatment of neurological diseases, multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, and myasthenia gravis; and RPI-MN for the treatment of the viral diseases, HIV/AIDS, and hepatitis-C. In addition, the company, through its other subsidiary, Designer Diagnostics, Inc., engages in the sale of diagnostic test kits that are used for the identification of infectious human diseases, such as tuberculosis and mycobacterium avium-intracellulare. Nutra Pharma, formerly known as Exotic-Bird.com, was founded in 2000 and is based in Boca Raton, Florida.

NPHC News Yesterday, Nutra Pharma announced that its wholly-owned drug discovery subsidiary, ReceptoPharm, will provide RPI-78M under compassionate release to patients previously enrolled in the Phase IIb/IIIa clinical study of Adrenomyeloneuropathy (AMN). RPI-78M is ReceptoPharm's leading drug candidate for treating neurological and autoimmune disorders. "This is an exciting time for Nutra Pharma as we await the clinical findings from our recent study," said Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation. "While the data from this trial is being reviewed and cleaned for analysis, we are pleased to be able to provide RPI-78M, under compassionate release to those patients who were enrolled in the trial and wish to remain on the drug,"

About StockGuru.com:

StockGuru.com is an investment information web site for smallcap and over-the-counter bulletin board stocks. StockGuru features daily email alerts to members, company profiles, audio interviews of CEO's or other key executives, and company news. Company and financial reports are authored by business analysts. To join our email alert list, please visit: http://www.stockguru.com/index.php?option=com_content&view=article&id=31&Itemid=5

About ShareholderVision.com:

Occasionally companies mentioned are also featured at ShareholderVision.com. This innovative web site featuring company videos of corporate executives and key personnel. All videos are shot in high-definition format and are edited for content purposes.

To feature your publicly traded company in our alerts, or to discuss our complete services, please contact: John Pentony at (469) 252-3031, or you email us at email: john@stockguru.com and we will gladly send you more information on featuring your company with StockGuru.com

Stockguru.com ("SG") provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.Stockguru.com or mentioned herein.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements.

CONTACT: John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: john@stockguru.com WWW: http://www.Stockguru.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

More News:   Market Updates | Stock Alerts | All Trading News | Stock Index